News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
625,570 Results
Type
Article (49855)
Company Profile (109)
Press Release (575600)
Multimedia
Podcasts (161)
Webinars (28)
Section
Business (188397)
Career Advice (2845)
Deals (31128)
Drug Delivery (161)
Drug Development (70646)
Employer Resources (173)
FDA (15699)
Job Trends (14113)
News (289872)
Policy (31484)
Tag
2027 BioCapital Standard (1)
2027 BioMidwest Elite (2)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (2)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (1)
2027 Biotech Beach Elite (2)
2027 Genetown Elite (3)
2027 Genetown Standard (4)
2027 Pharm Country Elite (2)
2027 Pharm Country Standard (7)
Academia (2686)
Academic (2)
Accelerated approval (58)
ADA (49)
Adcomms (37)
Allergies (193)
Alliances (42944)
ALS (240)
Alzheimer's disease (1862)
Antibody-drug conjugate (ADC) (530)
Approvals (16101)
Artificial intelligence (786)
ASCO (313)
Autoimmune disease (354)
Automation (67)
Bankruptcy (304)
Best Places to Work (10670)
BIO (67)
BIOSECURE Act (22)
Biosimilars (253)
Biotechnology (72)
Bladder cancer (208)
Brain cancer (78)
Breast cancer (798)
Cancer (6321)
Cardiovascular disease (545)
Career advice (2412)
Career pathing (53)
CAR-T (355)
CDC (76)
Celiac Disease (3)
Cell therapy (974)
Cervical cancer (55)
Clinical research (62902)
Collaboration (2250)
Commercialization (1)
Company closure (7)
Compensation (980)
Complete response letters (105)
COVID-19 (2804)
CRISPR (118)
C-suite (1233)
Cystic fibrosis (151)
Data (8473)
Decentralized trials (3)
Denatured (28)
Depression (192)
Dermatology (97)
Diabetes (672)
Diagnostics (6985)
Digital health (64)
Diversity (10)
Diversity, equity & inclusion (40)
Drug discovery (380)
Drug pricing (238)
Drug shortages (36)
Duchenne muscular dystrophy (320)
Earnings (65341)
Editorial (79)
Employer branding (19)
Employer resources (151)
Events (86918)
Executive appointments (1122)
FDA (19664)
Fibrodysplasia Ossificans Progressiva (10)
Friedreich's ataxia (20)
Frontotemporal dementia (36)
Funding (1847)
Gene editing (255)
Generative AI (67)
Gene therapy (793)
GLP-1 (1212)
Government (4807)
Grass and pollen (7)
Guidances (417)
Healthcare (17165)
Hematology (179)
HIV (96)
Huntington's disease (64)
Idiopathic pulmonary fibrosis (1)
IgA nephropathy (113)
Immunology and inflammation (332)
Immuno-oncology (115)
Indications (210)
Infectious disease (3192)
Inflammatory bowel disease (221)
Inflation Reduction Act (14)
Influenza (143)
Intellectual property (311)
Interviews (546)
IPO (14525)
IRA (54)
Job creations (3708)
Job search strategy (1976)
JPM (71)
Kidney cancer (23)
Labor market (117)
Layoffs (668)
Leadership (54)
Legal (8388)
Liver cancer (99)
Longevity (36)
Lung cancer (849)
Lymphoma (485)
Machine learning (67)
Management (61)
Manufacturing (1190)
Marketing (7)
MASH (222)
Medical affairs (1)
Medical device (12599)
Medtech (12768)
Mergers & acquisitions (17925)
Metabolic disorders (1740)
mRNA (250)
Multiple sclerosis (204)
NASH (22)
Neurodegenerative disease (508)
Neuropsychiatric disorders (129)
Neuroscience (3573)
Neurotech (1)
NextGen: Class of 2026 (6087)
Non-profit (4458)
Now hiring (59)
Obesity (827)
Opinion (367)
Ovarian cancer (239)
Pain (270)
Pancreatic cancer (348)
Parkinson's disease (391)
Partnered (36)
Patents (643)
Patient recruitment (772)
Peanut (64)
People (50900)
Pharmaceutical (29)
Pharmacy benefit managers (35)
Phase 1 (18760)
Phase 2 (27407)
Phase 3 (21945)
Pipeline (9929)
Policy (388)
Postmarket research (2305)
Preclinical (7414)
Press Release (65)
Prostate cancer (328)
Psychedelics (72)
Radiopharmaceuticals (318)
Rare diseases (1252)
Real estate (5861)
Recruiting (69)
Regulatory (24234)
Reports (54)
Research institute (2443)
Resumes & cover letters (450)
Rett syndrome (47)
RNA editing (23)
RSV (98)
Schizophrenia (193)
Series A (313)
Series B (235)
Service/supplier (5)
Sickle cell disease (123)
Special edition (31)
Spinal muscular atrophy (173)
Sponsored (52)
Startups (3505)
State (2)
Stomach cancer (19)
Supply chain (136)
Tariffs (100)
The Weekly (130)
Vaccines (1218)
Venture capital (134)
Weight loss (563)
Women's health (138)
Worklife (23)
Date
Today (113)
Last 7 days (417)
Last 30 days (1945)
Last 365 days (28882)
2026 (16173)
2025 (28543)
2024 (31820)
2023 (35338)
2022 (45888)
2021 (49613)
2020 (48604)
2019 (42649)
2018 (32416)
2017 (29538)
2016 (28371)
2015 (32716)
2014 (26200)
2013 (22918)
2012 (22090)
2011 (22735)
2010 (19989)
Location
Africa (880)
Alabama (91)
Alaska (5)
Arizona (272)
Arkansas (14)
Asia (42658)
Australia (6951)
California (12714)
Canada (3805)
China (1523)
Colorado (545)
Connecticut (567)
Delaware (411)
Europe (88550)
Florida (1977)
Georgia (406)
Hawaii (3)
Idaho (58)
Illinois (1120)
India (101)
Indiana (599)
Iowa (22)
Japan (614)
Kansas (122)
Kentucky (45)
Louisiana (61)
Maine (83)
Maryland (1422)
Massachusetts (8687)
Michigan (350)
Minnesota (632)
Mississippi (7)
Missouri (149)
Montana (30)
Nebraska (27)
Nevada (154)
New Hampshire (83)
New Jersey (3564)
New Mexico (29)
New York (3477)
North Carolina (1624)
North Dakota (10)
Northern California (6362)
Ohio (418)
Oklahoma (20)
Oregon (40)
Pennsylvania (2528)
Puerto Rico (31)
Rhode Island (46)
South America (1234)
South Carolina (86)
South Dakota (1)
Southern California (5062)
Tennessee (208)
Texas (2088)
United States (45071)
Utah (424)
Vermont (2)
Virginia (340)
Washington D.C. (74)
Washington State (1047)
West Virginia (4)
Wisconsin (149)
Wyoming (2)
625,570 Results for "f hoffmann la roche ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Huntington’s disease
Roche scraps 2 Huntington’s studies, handing Ionis more bad news
Roche’s decision to discontinue the Ionis-partnered trials came soon after the biotech sustained a late-stage failure in ATTR-CM.
July 10, 2026
·
2 min read
·
Tristan Manalac
Huntington’s disease
Exit of Roche’s embattled Huntington’s drug ‘tightens’ case for Wave’s more selective ASO
The failure of Roche’s Ionis-partnered tominersen in Huntington’s disease may indicate that Wave Life Sciences’ allele-specific antisense oligonucleotide candidate WVE-003 is on the right track, according to analysts at Rodman & Renshaw.
July 13, 2026
·
4 min read
·
Heather McKenzie
Press Releases
Jyong Biotech Ltd. Files Annual Report on Form 20-F for Fiscal Year 2025
May 15, 2026
·
3 min read
Press Releases
FDA accepts New Drug Application for Roche’s giredestrant in ER-positive early-stage breast cancer, the first and only oral SERD with positive phase III results in the curative setting
June 2, 2026
·
12 min read
Inflammatory bowel disease
Merck posts ‘encouraging’ Phase 3 ulcerative colitis data but Roche challenge looms
Given its intravenous route of administration, Merck’s tulisokibart will likely “need to be meaningfully improved” over Roche’s afimkibart, which can be given subcutaneously, BMO Capital Markets analysts said. Both assets are being tested for ulcerative colitis.
June 23, 2026
·
2 min read
·
Tristan Manalac
Podcast
Roche Makes Obesity Splash, Moderna Cans Vaccine Trials, Sarepta’s New Data, More
Roche’s obesity candidate achieves 22.5% weight loss in Phase II; Moderna pulls the plug on late-stage vaccine trials as Health Secretary Robert F. Kennedy’s anti-vaccine policies and rhetoric continues; and embattled gene therapy maker Sarepta announces new data in Duchenne muscular dystrophy.
January 28, 2026
·
1 min read
·
Heather McKenzie
Manufacturing
Roche licensing pact clears generic drugmakers to manufacture antiviral flu drug
By partnering with a UN-backed body, Roche has enabled companies to make the medicine for supply in 129 countries.
May 21, 2026
·
2 min read
·
Nick Paul Taylor
Press Releases
Precipio to Present at the Planet MicroCap Las Vegas
June 12, 2026
·
5 min read
Spinal muscular atrophy
Roche Ends Run for Muscular Atrophy Drug, Leaving Door Open for Competitors
The main beneficiary of Roche’s discontinuation of an investigational spinal muscular atrophy drug is Scholar Rock, which was hobbled by manufacturing concerns at a Novo Nordisk facility last year but is now nearing a potential resolution.
March 20, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Polyrizon Ltd. Files Annual Report on Form 20-F for the Fiscal Year Ended December 31, 2025
March 26, 2026
·
3 min read
1 of 62,557
Next
